IL10 and osteoarthritis: Modulation of IL-10 expression by MSCs has previously been reported in in vivo models of inflammatory [77] and neuropathic [36] pain, but also in many other models of inflammation, e.g. sepsis [78], osteoarthritis [61] or traumatic brain injury [62].